Advanced Search

Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2004 April;70(4) > Minerva Anestesiologica 2004 April;70(4):189-91



A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care

Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,036

Frequency: Monthly

ISSN 0375-9393

Online ISSN 1827-1596


Minerva Anestesiologica 2004 April;70(4):189-91

SMART 2004 - Milan, May 12-14, 2004 


Hemofiltration in the prevention of radiocontrast agent induced nephropathy

Marenzi G., Bartorelli A. L.

Monzino Heart Center, IRCCS, Institute of Cardiology, University of Milan, Milan, Italy

Aim. The aim of the study was to investigate the role of hemofiltration in preventing contrast nephropathy in patients with renal failure.
Methods. We randomized 114 renal failure patients undergoing percutaneous coronary interventions (PCI) to either peri-procedural hemofiltration or saline hydration.
Results. Contrast nephropathy occurred in 5% of hemofiltration-treated patients and in 50% in controls (P<0.01). In-hospital event rate as well as in-hospital and 1-year mortality rates were lower in patients treated with hemofiltration.
Conclusion. In patients with renal failure undergoing PCI, peri-procedural hemofiltration is effective for the prevention of contrast nephropathy, and is associated with improved in-hospital and long-term outcome.

language: English


top of page